Virpax Pharmaceuticals Inc. (NASDAQ: VRPX) Stock Information | RedChip

Virpax Pharmaceuticals Inc. (NASDAQ: VRPX)


$0.7198
+0.0008 ( +0.11% ) 62.8K

Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.

Market Data


Open


$0.7198

Previous close


$0.7190

Volume


62.8K

Market cap


$3.51M

Day range


$0.6680 - $0.7230

52 week range


$0.3625 - $8.0000

SEC Filings


Form Type Description Pages Date
4 Insider transactions 2 Jan 31, 2024
4 Insider transactions 2 Jan 31, 2024
4 Insider transactions 2 Jan 31, 2024
4 Insider transactions 2 Jan 31, 2024
4 Insider transactions 2 Jan 31, 2024
4 Insider transactions 2 Jan 31, 2024
8-k 8K-related 12 Dec 29, 2023
8-k 8K-related 12 Dec 13, 2023
def Proxies and info statements 4 Dec 07, 2023
8-k 8K-related 13 Dec 07, 2023

Latest News